Literature DB >> 33559758

In Vitro Detected hly II Cytotoxin in a Strain of Staphylococcus aureus (BM S-2) and Plant-Derived Aromatic Components: a Molecular Docking Study.

Debadarshee Das Mohapatra1, Smaranika Pattnaik2, Sruti Panda3.   

Abstract

In time, diagnosis and detection of virulence factor and its pathogenomics study continues to grow and this leads to novel treatments for infectious diseases. The objective of this study was to detect and characterise virulence genes in a haemolytic strain of Staphylococcus aureus in vitro and molecular interaction studies with herbal essential oil components in silico. A hospital biosample-isolated strain of Staphylococcus aureus (BMS-2) was resistant towards Cephalosporin. The PCR-amplified FASTA nucleotide sequence was identical with S. aureus strains absolutely. The calculated GC value was 34.05%. The translated protein sequence was identified with a conserved domain of hlyII β-channel forming cytolysin belonging to leukocidin superfamily and was predicted as a stable, non-transmembrane protein comprising B cell epitopes. Structurally, the protein was found to be composed of α helix, π-helix, extended strands, β-sheet, turn and bends with atomic composition as C658H1026N174O200S2. The molecular docking studies made between the HlyII cytolysin (receptor) and wet lab studied essential oil components (citral a, citronellol, eucalyptol, eugenol, geraniol, linalool, menthol, piperine and thymol) as ligands using Autodock 1.5.6 tool had inferred about prevalence of hydrogen bonds as well as covalent bonds in the intermolecular interactions. Amino acids like Tyr68, Tyr 69, Asn106, Asp67 and Asn106 were observed to be the most active residues for H-bond and hydrophobic bonds respectively. Only geraniol had interaction with glycine residue of the toxin molecule. In conclusion, geraniol with the highest ligand efficiency was observed to be the most potent phyto-constituent interacting with the in vitro detected hlyII cytotoxin.

Entities:  

Keywords:  Essential oil components; In vitro detection; Molecular docking; hly II cytotoxin; α-Haemolysis

Year:  2021        PMID: 33559758     DOI: 10.1007/s12010-021-03510-2

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  23 in total

1.  Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.

Authors:  Alan R Hauser; Joan Mecsas; Donald T Moir
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

2.  New insights into the prevention of staphylococcal infections and toxic shock syndrome.

Authors:  Ying-Chi Lin; Marnie L Peterson
Journal:  Expert Rev Clin Pharmacol       Date:  2010-11-01       Impact factor: 5.045

Review 3.  Small Molecules That Sabotage Bacterial Virulence.

Authors:  Benjamin K Johnson; Robert B Abramovitch
Journal:  Trends Pharmacol Sci       Date:  2017-02-14       Impact factor: 14.819

4.  Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections.

Authors:  Stefanie Wagner; Roman Sommer; Stefan Hinsberger; Cenbin Lu; Rolf W Hartmann; Martin Empting; Alexander Titz
Journal:  J Med Chem       Date:  2016-02-18       Impact factor: 7.446

5.  Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients.

Authors:  Heather G Ahlgren; Andrea Benedetti; Jennifer S Landry; Joanie Bernier; Elias Matouk; Danuta Radzioch; Larry C Lands; Simon Rousseau; Dao Nguyen
Journal:  BMC Pulm Med       Date:  2015-06-21       Impact factor: 3.317

Review 6.  Staphylococcus aureus α-toxin: nearly a century of intrigue.

Authors:  Bryan J Berube; Juliane Bubeck Wardenburg
Journal:  Toxins (Basel)       Date:  2013-06       Impact factor: 4.546

7.  Genotypic Diversity of Staphylococcus aureus α-Hemolysin Gene (hla) and Its Association with Clonal Background: Implications for Vaccine Development.

Authors:  Meng Xiao; Rui Zhao; Qi Zhang; Xin Fan; Matthew V N O'Sullivan; Dong-Fang Li; Xin-Ying Wang; Hong-Long Wu; Fanrong Kong; Ying-Chun Xu
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

8.  Manipulating virulence factor availability can have complex consequences for infections.

Authors:  Michael Weigert; Adin Ross-Gillespie; Anne Leinweber; Gabriella Pessi; Sam P Brown; Rolf Kümmerli
Journal:  Evol Appl       Date:  2016-10-24       Impact factor: 5.183

Review 9.  The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.

Authors:  John R Brannon; Maria Hadjifrangiskou
Journal:  Drug Des Devel Ther       Date:  2016-05-27       Impact factor: 4.162

10.  Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of α-hemolysin.

Authors:  Jianfeng Wang; Xuan Zhou; Wenhua Li; Xuming Deng; Yanhong Deng; Xiaodi Niu
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

View more
  1 in total

1.  Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 Mpro: Bioinformatics Approach.

Authors:  Kaushik Kumar Bharadwaj; Tanmay Sarkar; Arabinda Ghosh; Debabrat Baishya; Bijuli Rabha; Manasa Kumar Panda; Bryan Raveen Nelson; Akbar B John; Hassan I Sheikh; Bisnu Prasad Dash; Hisham Atan Edinur; Siddhartha Pati
Journal:  Appl Biochem Biotechnol       Date:  2021-07-01       Impact factor: 2.926

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.